Products

What will AGI do for Adenosine phosphate?

This classification denotes an aprt gene, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 415SHH325A. European Medicines Agency schedules Adenosine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05267MIG. Adenosine phosphate generally arises in the molecular formula C10H14N5O7P. The term ADENOSINE PHOSPHATE is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule adenosine phosphate under HS 29349990 and SITC 51579. As of Q4 2014, ADENOSINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Adenosine phosphate bears US NLM identifiers UMLS ID C0001413 and NCI Concept Code C83606. SMILES: C1NC(C2C(N1)N(CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N.

How AGI delivers it

Four ways AGI delivers for Adenosine phosphate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Adenosine phosphate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Adenosine phosphate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Adenosine phosphate connects

measured by

  • Assay Potencymodel
  • Chemical Puritymodel
  • Residual Solvent Contentmodel